Samenvatting
Post-translational modifications of proteins, such as acetylation, are important regulatory events in eukaryotic cells. Reversible acetylations of histones and non-histone proteins regulate gene expression and protein activity. Acetylation levels of proteins are regulated by a dynamic equilibrium between acetylation by (histone) acetyltransferases and deacetylation by (histone) deacetylases. Alterations in this equilibrium can result in pathological states. Inflammation is a physiological response that, under certain conditions, turns into a disease. This review focuses on the crucial regulatory roles of protein acetylation in NF-kappa B-mediated inflammation and the potential applications of small-molecule inhibitors of acetylation for the treatment of inflammatory diseases.
Originele taal-2 | English |
---|---|
Pagina's (van-tot) | 504-511 |
Aantal pagina's | 8 |
Tijdschrift | Drug Discovery Today |
Volume | 16 |
Nummer van het tijdschrift | 11-12 |
DOI's | |
Status | Published - jun.-2011 |